Detalhe da pesquisa
1.
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Pharmacogenomics J
; 17(4): 344-350, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27139155
2.
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Ann Oncol
; 25(2): 366-71, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24347519
3.
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.
ESMO Open
; 8(1): 100747, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36563519
4.
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.
ESMO Open
; 7(3): 100483, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35576695
5.
[Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? No]. / Haben die neuen Mammakarzinom-Subtypen (Luminal-A, B usw.) praktische Bedeutung? Contra.
Dtsch Med Wochenschr
; 138(41): 2097, 2013 Oct.
Artigo
Alemão
| MEDLINE | ID: mdl-24085365